O'Shaughnessy Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,059	Closed	-$341K	–	1049
2019 Q2	$341K	Sell	4,059 -7,071	-64%	-$636K	0.01%	443
2019 Q1	$1.06M	Sell	11,130 -15,013	-57%	-$1.35M	0.03%	257
2018 Q4	$1.85M	Sell	26,143 -5,683	-18%	-$436K	0.05%	192
2018 Q3	$2.7M	Buy	31,826 +9	+0%	+$902	0.06%	165
2018 Q2	$3.67M	Buy	31,817 +4,866	+18%	+$486K	0.08%	147
2018 Q1	$2.18M	Buy	26,951 +21,310	+378%	+$1.64M	0.05%	177
2017 Q4	$331K	Buy	+5,641	New	+$282K	0.01%	446

Other funds holding ENTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

O'Shaughnessy Asset Management's ENTA Position: Q3 2019 in Review

O'Shaughnessy Asset Management sold out of Enanta Pharmaceuticals (ENTA) in Q3 2019, closing a stake of 4,059 shares — an estimated $341K sold.

O'Shaughnessy Asset Management first reported a position in ENTA in Q4 2017 and held it in 7 quarters. The position peaked at $3.67M in Q2 2018. 176 funds tracked by Wall St. Rank hold ENTA as of Q3 2019.

O'Shaughnessy Asset Management reported no remaining Enanta Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
O'Shaughnessy Asset Management sold 4,059 Enanta Pharmaceuticals shares in Q3 2019, an estimated $341K.
O'Shaughnessy Asset Management first reported a position in Enanta Pharmaceuticals in Q4 2017 and held it in 7 quarters.
O'Shaughnessy Asset Management's Enanta Pharmaceuticals position peaked at $3.67M in Q2 2018.
176 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q3 2019.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.